Kezar Life Sciences, Inc.
Board Member, CEO
2026-05-11–present
Board Member
Kezar Life Sciences, Inc.
CEO
Kezar Life Sciences, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Kevin Tang is recorded as Board Member and CEO at Kezar Life Sciences, Inc.. Kezar Life Sciences, Inc. reported in an 8-K filed May 11, 2026 that Kevin Tang was appointed Chief Executive Officer, effective May 11, 2026.
“The sole director of Merger Sub immediately prior to the Effective Time was Kevin Tang. The executive officers of Merger Sub immediately prior to the Effective Time were Kevin Tang, Chief Executive Officer, Ryan Cole, Chief Operating Officer, Michael Hearne, Chief Financial Officer, and Stephen Robertson, Chief Legal Officer, Corporate Secretary and Chief Compliance Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Kezar Life Sciences, Inc.
Board Member
SEC 8-K
2026-05-11–present
Kezar Life Sciences, Inc.
CEO
SEC 8-K
2026-05-11–present
Recorded roles and call appearances connecting this person to public companies.
Kezar Life Sciences, Inc.
Board Member, CEO
2026-05-11–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.